SCOUT Report – SAVI SCOUT® Localization Improves Breast Surgery Operating Room Start Times Compared with Wire Localization


Data presented at the American Society of Breast Surgeons 18th Annual Meeting demonstrate SCOUT® radar localization system significantly reduces operating room (OR) start times and improves workflow for surgical procedures targeting non-palpable breast lesions.
Mary K. Hayes, M.D., Chief of Women’s Imaging at Memorial Healthcare System in Hollywood, Florida, presented a poster titled, “SAVI SCOUT® Localization Improves Breast Surgery Operating Room Start Times Compared with Wire Localization,” which reported results from a prospective study of OR start time delays in procedures using SCOUT or wire technology for pre-operative breast lesion localization.
Two surgeons were given the option of same day wire placement or SCOUT placement 0-30 days prior to surgery, and delayed OR start times were recorded for procedures conducted between January 1, 2015 and October 1, 2016. Start time information from 159 patients who underwent localizations for non-palpable breast lesions (30 wire localizations and 129 SCOUT localizations) was included in the analysis. Average OR start delay was 40 minutes for wire and 11 minutes for SCOUT localizations. The 29-minute difference was statistically significant (95%CI P < .001) and reflects a 72.5 percent decrease in delay time. No same day cancellations were attributed to SCOUT localization.
While operating room costs vary by geography, it is estimated that OR set up fees are about $3,000 and procedure fees average about $68/minute.
[ii] A 29-minute reduction in OR waiting time would results in cost savings of $1,972, and eliminating same day cancellations would also provide significant cost benefits.

Charles Cox, M.D., Professor of Surgery and McCann Foundation Endowed Professor of Breast Surgery, University of South Florida Morsani College of Medicine, Director of the USF Breast Health Pro gram, and Medical Director of Morsani Ambulatory Surgery Center, presented additional data on workflow efficiencies associated with SCOUT in a poster titled, “Efficiency Impact of Radar Localization.” – Click here for poster

The reported study was based on the results of evaluation forms that radiologists (n=14) and surgeons (n=13) completed describing their experience with SCOUT compared with their prior experience using wire localization. Ten of the responding radiologists answered the query about workflow improvements, of which 90% indicated an improvement with SCOUT compared with wire localization. This improvement was largely associated with the ability to schedule localization at the convenience of the patient and the radiology department, rather than performing localization the day of the surgical procedure.
Among the 13 responding surgeons, nine performed SCOUT placement at least one day prior to surgery (average 2.8 days). All surgeons reported improvements in surgical start times, decreased patient waiting times and reduction in OR delays with SCOUT compared with wire localization. The reported reduction in OR delays was greater among surgeons who performed SCOUT localizations at least one day prior to surgery compared with surgeons who used SCOUT the day of surgery.
[i],[ii] SAVI SCOUT® Localization Improves Breast Surgery Operating Room Start Times compared with Wire Localization. Mary K. Hayes MD, Erica V Bloomquist MD, Heather Wright, MD

SCOUT® Honored as Finalist in the 2017 Medical Design Excellence Awards
Novel SCOUT technology is a leading innovation in wire-free breast localization



We are pleased to announce that SCOUT radar breast localization system has been selected as a finalist in the 19th Annual Medical Design Excellence Awards competition.
MDEA are the medtech industry’s premier design competition recognizes significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.  The awards program celebrates the accomplishments of the medical device manufacturers and the many people behind the scenes-engineers, scientists, designers, and clinicians-who are responsible for the cutting-edge products that are saving lives, improving patient healthcare and transforming medtech-one innovation at a time.
“We are honored to be recognized by the MDEA judges,” said Eduardo Chi Sing, Chief Technology Officer at Cianna Medical.  “Hospitals across the country continue to adopt radar technology as a versatile and clinically effective tool for breast tumor localization, and it is emerging as the technology of choice over wire localization.”


This e-newsletter is brought to you by Cianna  Medical, Inc., a women’s health company dedicated to the innovative treatment of early-stage breast cancer. As the only company dedicated exclusively to breast conservation therapy, Cianna’s commitment is to improve care and reduce the burden breast cancer treatment places on nearly 300,000 women and their loved ones each year.